NYSE:HUM Humana (HUM) Stock Price, News & Analysis $357.86 -7.28 (-1.99%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$357.18▼$369.1750-Day Range$345.56▼$404.5252-Week Range$298.61▼$530.54Volume1.08 million shsAverage Volume1.63 million shsMarket Capitalization$43.12 billionP/E Ratio22.28Dividend Yield0.99%Price Target$398.70 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Humana alerts: Email Address Humana MarketRank™ Stock AnalysisAnalyst RatingHold2.43 Rating ScoreUpside/Downside11.4% Upside$398.70 Price TargetShort InterestHealthy1.87% of Float Sold ShortDividend StrengthModerateBased on Four FactorsSustainability-0.75Upright™ Environmental ScoreNews Sentiment0.81Based on 19 Articles This WeekInsider TradingN/AProj. Earnings Growth22.43%From $16.14 to $19.76 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.83 out of 5 starsMedical Sector28th out of 910 stocksHospital & Medical Service Plans Industry2nd out of 11 stocks 3.2 Analyst's Opinion Consensus RatingHumana has received a consensus rating of Hold. The company's average rating score is 2.43, and is based on 9 buy ratings, 12 hold ratings, and no sell ratings.Amount of Analyst CoverageHumana has been the subject of 9 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Humana's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.87% of the float of Humana has been sold short.Short Interest Ratio / Days to CoverHumana has a short interest ratio ("days to cover") of 1.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Humana has recently increased by 4.17%, indicating that investor sentiment is decreasing. Previous Next 2.5 Dividend Strength Dividend YieldHumana pays a meaningful dividend of 1.01%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthHumana does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Humana is 22.04%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Humana will have a dividend payout ratio of 17.91% next year. This indicates that Humana will be able to sustain or increase its dividend.Read more about Humana's dividend. Previous Next 3.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreHumana has received a 52.17% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Health insurance services for individuals", "Health insurance services for groups", and "Physical retail of pharmaceuticals at a pharmacy" products. See details.Environmental SustainabilityThe Environmental Impact score for Humana is -0.75. Previous Next 2.1 News and Social Media Coverage News SentimentHumana has a news sentiment score of 0.81. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.55 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 19 news articles for Humana this week, compared to 20 articles on an average week.Search InterestOnly 15 people have searched for HUM on MarketBeat in the last 30 days. This is a decrease of -48% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Humana to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Humana insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.32% of the stock of Humana is held by insiders.Percentage Held by Institutions92.38% of the stock of Humana is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Humana's insider trading history. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for Humana are expected to grow by 22.43% in the coming year, from $16.14 to $19.76 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Humana is 22.28, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 128.08.Price to Earnings Ratio vs. SectorThe P/E ratio of Humana is 22.28, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 114.96.Price to Earnings Growth RatioHumana has a PEG Ratio of 3.16. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHumana has a P/B Ratio of 2.58. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Humana's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Golden CrestBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security.>> Get Your FREE Wealth Protection Guide << About Humana Stock (NYSE:HUM)Humana Inc., together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, life insurance, and other supplemental health benefits, as well as administrative services only products to individuals and employer groups; military services, such as TRICARE T2017 East Region contract; and engages in the operations of pharmacy benefit manager business. Further, it operates pharmacies and senior focused primary care centers; and offers home solutions services, such as home health, hospice, and other services to its health plan members, as well as to third parties. The company sells its products through employers and employees, independent brokers and agents, sales representatives, and digital insurance agencies. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.Read More HUM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart HUM Stock News HeadlinesAugust 7, 2024 | marketbeat.comTenet Healthcare Stock Sees Strong Gains from Acute Care Boom (HUM)Hospital and ambulatory care operator Tenet Healthcare Co. (NYSE: THC) is operating in the sweet spot of healthcare these days.August 7, 2024 | marketbeat.comMedical Technology Stock Benefits from Rising Acute Care Demand (HUM)Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry.September 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.September 7 at 6:45 AM | americanbankingnews.comHumana (NYSE:HUM) PT Raised to $400.00 at Royal Bank of CanadaSeptember 4 at 3:06 PM | msn.comTeam Canada silver medalists Melissa Humana Parades and Brandie Wilkerson join us LIVESeptember 4 at 3:06 PM | seekingalpha.comHumana extends gains as inpatient activity meets expectationsSeptember 4 at 5:04 AM | msn.comLouisville Zoo offering special discounts for Grandparents' Day and 'Senior Sundays'September 4 at 12:03 AM | msn.comLMH Health to stop accepting Aetna and Humana Medicare Advantage plansSeptember 7, 2024 | Weiss Ratings (Ad)“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.September 3, 2024 | markets.businessinsider.comWells Fargo Remains a Buy on Humana (HUM)September 2, 2024 | americanbankingnews.comHumana Inc. (NYSE:HUM) Receives Consensus Recommendation of "Hold" from BrokeragesAugust 30, 2024 | marketwatch.comHumana Inc. stock rises Friday, still underperforms marketAugust 29, 2024 | msn.comHere's Why Humana (HUM) Rebounded in Q2August 29, 2024 | msn.comBangor Woman: ‘Dollars over patients’: Mainers scrambling after Northern Light Health drops Humana Medicare Advantage PlanAugust 28, 2024 | msn.comHere’s Why Humana (HUM) Rebounded in Q2August 27, 2024 | marketwatch.comHumana Inc. stock rises Tuesday, still underperforms marketAugust 27, 2024 | forbes.comCan Humana Stock Return To $500 From Its Current Level Of $350?August 23, 2024 | msn.comBaby left at Humana building in downtown Louisville; police looking for manSee More Headlines Receive HUM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Humana and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 7/26 Dividend6/28/2024Dividend Payable7/26/2024Last Earnings7/31/2024Today9/07/2024Ex-Dividend for 10/25 Dividend9/30/2024Dividend Payable10/25/2024Next Earnings (Estimated)11/06/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Hospital & medical service plans Sub-IndustryManaged Health Care Current SymbolNYSE:HUM CUSIP44485910 CIK49071 Webwww.humana.com Phone(502) 580-1000Fax502-580-3639Employees67,600Year Founded1961Price Target and Rating Average Stock Price Target$398.70 High Stock Price Target$579.00 Low Stock Price Target$310.00 Potential Upside/Downside+11.4%Consensus RatingHold Rating Score (0-4)2.43 Research Coverage21 Analysts Profitability EPS (Most Recent Fiscal Year)$16.06 Trailing P/E Ratio22.28 Forward P/E Ratio22.17 P/E Growth3.16Net Income$2.49 billion Net Margins1.53% Pretax Margin2.18% Return on Equity16.12% Return on Assets5.26% Debt Debt-to-Equity Ratio0.70 Current Ratio1.66 Quick Ratio1.66 Sales & Book Value Annual Sales$112.04 billion Price / Sales0.38 Cash Flow$34.61 per share Price / Cash Flow10.34 Book Value$138.93 per share Price / Book2.58Miscellaneous Outstanding Shares120,501,000Free Float120,115,000Market Cap$43.12 billion OptionableOptionable Beta0.51 Social Links 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Bruce Dale Broussard (Age 62)CEO & Director Comp: $1.94MMs. Susan Marie Diamond (Age 50)Chief Financial Officer Comp: $1.03MMr. Joseph C. Ventura (Age 47)Chief Legal Officer Comp: $840.36kMr. George Renaudin II (Age 55)President of Medicare & Medicaid Comp: $850.28kDr. Sanjay K. Shetty M.B.A. (Age 50)M.D., President of CenterWell Comp: $2.73MMr. James A. Rechtin M.B.A. (Age 53)President & COO Mr. John-Paul William Felter (Age 40)Senior VP, Chief Accounting Officer, Principal Accounting Officer & Controller Mr. Eric TagliereSenior VP & CTOMr. Samir M. Deshpande (Age 59)Chief Information Officer Mr. Timothy S. Huval (Age 58)Chief Administrative Officer Comp: $1.68MMore ExecutivesKey CompetitorsElevance HealthNYSE:ELVThe Cigna GroupNYSE:CICenteneNYSE:CNCMolina HealthcareNYSE:MOHUnitedHealth GroupNYSE:UNHView All CompetitorsInsiders & InstitutionsSanctuary Advisors LLCBought 8,942 shares on 9/5/2024Ownership: 0.007%Clear Rock Advisors LLCBought 119 shares on 9/3/2024Ownership: 0.004%Heritage Oak Wealth Advisors LLCBought 9,248 shares on 8/28/2024Ownership: 0.008%Dana Investment Advisors Inc.Sold 191 shares on 8/27/2024Ownership: 0.006%Teachers Retirement System of The State of KentuckySold 299 shares on 8/26/2024Ownership: 0.008%View All Insider TransactionsView All Institutional Transactions Should I Buy Humana Stock? HUM Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Humana Inc.: Humana Inc. stock price is currently at $358.55, showing a positive trend in recent trading. Analysts have set a consensus price target of $396.35, indicating potential for growth. Fifth Third Bancorp increased its holdings in Humana by 41.7% in the second quarter, reflecting confidence in the company. Recent analyst reports have upgraded Humana to "hold" and "buy" ratings, suggesting positive sentiment. Institutional investors and hedge funds continue to show interest in Humana, with significant stakes in the company. Cons Investors should be bearish about investing in Humana Inc. for these reasons: Humana's P/E ratio of 22.33 may indicate the stock is currently overvalued. The company's beta of 0.51 suggests lower volatility compared to the market average, potentially limiting short-term gains. While some analysts have upgraded Humana, others have maintained a "neutral" rating, indicating mixed opinions on the stock. Debt-to-equity ratio of 0.70 may raise concerns about the company's financial leverage. Despite recent positive movements, Humana's stock has faced resistance at certain price levels, signaling potential challenges ahead. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Tuesday, August 27, 2024. Please send any questions or comments about these Humana pros and cons to contact@marketbeat.com. HUM Stock Analysis - Frequently Asked Questions How have HUM shares performed this year? Humana's stock was trading at $457.81 at the beginning of 2024. Since then, HUM shares have decreased by 21.8% and is now trading at $357.86. View the best growth stocks for 2024 here. How were Humana's earnings last quarter? Humana Inc. (NYSE:HUM) issued its earnings results on Wednesday, July, 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping analysts' consensus estimates of $5.89 by $1.07. The firm's quarterly revenue was up 10.4% on a year-over-year basis. Read the conference call transcript. What is Bruce D. Broussard's approval rating as Humana's CEO? 1,597 employees have rated Humana Chief Executive Officer Bruce D. Broussard on Glassdoor.com. Bruce D. Broussard has an approval rating of 87% among the company's employees. Does Humana have any subsidiaries? Humana subsidiaries include Enclara Healthcare, Kindred Healthcare, American Eldercare, FPG, Metropolitan Health Networks, Certify Data Systems, Harris Rothenberg International, and more. Who are Humana's major shareholders? Humana's top institutional shareholders include Pzena Investment Management LLC (1.92%), Davis Selected Advisers (1.92%), Marshall Wace LLP (1.18%) and Legal & General Group Plc (0.98%). Insiders that own company stock include Bruce D Broussard, David A Jr/Ky Jones, Samir Deshpande, Timothy S Huval, Joseph C Ventura, Susan M Diamond, Jorge S Mesquita and William Kevin Fleming. View institutional ownership trends. How do I buy shares of Humana? Shares of HUM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Humana own? Based on aggregate information from My MarketBeat watchlists, some other companies that Humana investors own include UnitedHealth Group (UNH), NVIDIA (NVDA), Walt Disney (DIS), Visa (V), Mastercard (MA), Alibaba Group (BABA) and Boeing (BA). This page (NYSE:HUM) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humana Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humana With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.